about
Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?Skeletal effects of zoledronic acid in an animal model of chronic kidney diseaseCardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients.Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India.(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.Diseases of the parathyroid gland in chronic kidney disease.Osteoporosis in patients with diabetes after kidney transplantation.Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.Management of adynamic bone disease in chronic kidney disease: A brief review.Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activationTheoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary careSuboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic OsteodystrophyFragility Fractures in Chronic Kidney Disease: Assessment and Pharmacologic Management
P2860
Q28535084-D1D32CE3-7B05-493B-BEBE-1EE7FE2651A0Q33779709-A4471C31-6247-4CD2-983B-1F446B5E8684Q34572435-752D37D2-31F7-4D20-AD30-1B522DB09B3BQ36267767-928CE247-3B89-4CE0-9DAE-68BD47480AB6Q36801566-15901EA4-68AF-4098-ABAA-3337AD4AA2A7Q37015581-46F1D5C8-D7E7-448B-885C-6718A34E74CAQ37298652-229AB76A-09C9-4740-9A9D-5FBEC3C312F3Q37912038-9FB4A703-4257-4742-9F42-84F438BA1394Q39014553-63ECCC45-29E7-4141-9364-E877F4DC9840Q39255870-1A876F82-B1D2-4EFD-A858-8CDBCBF04D0CQ42688826-F9597605-4C27-48E4-B61D-72C4DE4C1857Q42727533-3DBF6481-32F1-4B5D-8C0A-4EE733A2FD73Q54917687-68942F08-E608-4502-8DF0-115524BCED34Q58715560-3E1DCE91-B96C-49F3-9666-F3437901CA3DQ58765036-8AF71271-D6E5-4C73-BAE9-45DD23792853Q59051207-6E121EAB-0302-42CB-8F2C-8BFF16094E48
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Adynamic bone disease-bone and beyond.
@en
type
label
Adynamic bone disease-bone and beyond.
@en
prefLabel
Adynamic bone disease-bone and beyond.
@en
P2860
P356
P1433
P1476
Adynamic bone disease-bone and beyond.
@en
P2093
Jürgen Floege
Vincent M Brandenburg
P2860
P304
P356
10.1093/NDTPLUS/SFN040
P577
2008-06-01T00:00:00Z